Good practice recommendations for paediatric outpatient parenteral antibiotic therapy (p-OPAT) in the UK: A consensus statement

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 2, 2015, Pages 360-373

  Patel, Sanjay ^a   Abrahamson, Ed ^b   Goldring, Stephen ^c   Green, Helen ^a   Wickens, Hayley ^d,e   Laundy, Matt ^f  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b CHELSEA AND WESTMINSTER HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c Hillingdon Hospital NHS Trust   (United Kingdom)

^d UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f ST GEORGE'S UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Ambulatory; Children; Stewardship

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; CONSENSUS; CYSTIC FIBROSIS; DRUG CHOICE; DRUG DELIVERY SYSTEM; EMERGENCY WARD; ENDOCARDITIS; GOOD CLINICAL PRACTICE; HEALTH CARE QUALITY; HOSPITAL READMISSION; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL DOCUMENTATION; MEDICAL ETHICS; MENINGITIS; OUTCOME ASSESSMENT; OUTPATIENT CARE; PAEDIATRIC OUTPATIENT PARENTERAL ANTIBIOTIC THERAPY; PATIENT MONITORING; PATIENT SATISFACTION; PEDIATRIC NURSE; PSYCHOLOGICAL WELL BEING; SECONDARY HEALTH CARE; TERTIARY HEALTH CARE; TREATMENT DURATION; UNITED KINGDOM; VASCULAR ACCESS; ADOLESCENT; AGE; AMBULATORY CARE; BACTERIAL INFECTIONS; CHILD; DISEASE MANAGEMENT; INFANT; INFUSION; NEWBORN; PRACTICE GUIDELINE; PRESCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DISEASE MANAGEMENT; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, PARENTERAL; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PRACTICE GUIDELINES AS TOPIC;

EID: 84922451058     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dku401     Document Type: Article

References (76)

1. Rucker RW, Harrison GM. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 1974; 54: 358-60.
2. Chapman AL, Seaton RA, Cooper MA et al. Good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults in the UK: a consensus statement. J Antimicrob Chemother 2012; 67: 1053-62.
3. Tice AD, Rehm SJ, Dalovisio JR et al. Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelines. Clin Infect Dis 2004; 38: 1651-72.
4. Torok ME, Chapman AL, Lessing MP et al. Outpatient parenteral antimicrobial therapy: recent developments and future prospects. Curr Opin Investig Drugs 2010; 11: 929-39.
5. Chapman AL, Dixon S, Andrews D et al. Clinical efficacy and costeffectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother 2009; 64: 1316-24.
6. Gilbert J, Robinson T, Littlewood JM. Home intravenous antibiotic treatment in cystic fibrosis. Arch Dis Child 1988; 63: 512-7.
7. Hooker L, Kohler J. Safety, efficacy, and acceptability of home intravenous therapy administered by parents of pediatric oncology patients. Med Pediatr Oncol 1999; 32: 421-6.
8. Kane RE, Jennison K, Wood C et al. Cost savings and economic considerations using home intravenous antibiotic therapy for cystic fibrosis patients. Pediatr Pulmonol 1988; 4: 84-9.
9. Warner BW, Kulick RM, Stoops MM et al. An evidenced-based clinical pathway for acute appendicitis decreases hospital duration and cost. J Pediatr Surg 1998; 33: 1371-5.
10. Hawkes N. Achieving Nicholson challenge requires fundamental rethink on NHS, conference hears. BMJ 2012; 344: e4175.
11. Ford J. The NHS is facing a deepening financial crisis. BMJ 2013; 347: f4422.
12. Royal College of Paediatrics and Child Health. Facing the Future: Standards for Paediatric Services. 2011. http://www.rcpch.ac.uk/facingthefuture.
13. UK Department of Health. Our Health, Our Care, Our Say: A New Direction for Community Services. 2006. www.official-documents.gov.uk/document/cm67/6737/6737.pdf.
14. Ashiru-Oredope D, Sharland M, Charani E et al. Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart-Then Focus. J Antimicrob Chemother 2012; 67 Suppl 1: i51-63.
15. UK Government. Health and Social Care Act 2008-Code of Practice on the Prevention and Control of Infections and Related Guidance. https ://www.gov.uk/government/uploads/system/uploads/attachment_data/ file/216227/dh_123923.pdf.
16. Cass H. RCPCH Responds to Francis Inquiry. 2013. http://www.rcpch.ac. uk/news/rcpch-responds-francis-inquiry.
17. Francis R. Report of the Mid Staffordshire NHS Foundation Trust Public Inquiry. 2013. www.midstaffspublicinquiry.com/report.
18. Gilbert DN, Dworkin RJ, Raber SR et al. Outpatient parenteral antimicrobial-drug therapy. N Engl J Med 1997; 337: 829-38.
19. Maraqa NF, Rathore MH. Pediatric outpatient parenteral antimicrobial therapy: an update. Adv Pediatr 2010; 57: 219-45.
20. Goldenberg RI, Poretz DM, Eron LJ et al. Intravenous antibiotic therapy in ambulatory pediatric patients. Pediatr Infect Dis 1984; 3: 514-7.
21. Leaver J, Radivan F, Patel L et al. Home intravenous antibiotic therapy: practical aspects in children. J Roy Soc Med 1997; 90 Suppl 31: 26-33.
22. Greenhow TL, Hung YY, Herz AM. Changing epidemiology of bacteremia in infants aged 1 week to 3 months. Pediatrics 2012; 129: e590-6.
23. Baskin MN, O'Rourke EJ, Fleisher GR. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. J Pediatr 1992; 120: 22-7.
24. Dore-Bergeron MJ, Gauthier M, Chevalier I et al. Urinary tract infections in 1- to 3-month-old infants: ambulatory treatment with intravenous antibiotics. Pediatrics 2009; 124: 16-22.
25. Gauthier M, Chevalier I, Sterescu A et al. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Pediatrics 2004; 114: e469-76.
26. Pena DA, Viviani ST, Le Corre PN et al. [Treatment of urinary tract infections in febrile infants: experience of outpatient intravenous antibiotic treatment]. Rev Chilena Infectol 2009; 26: 350-4.
27. Kam AJ, Leal J, Freedman SB. Pediatric cellulitis: success of emergency department short-course intravenous antibiotics. Pediatr Emerg Care 2010; 26: 171-6.
28. Gouin S, Chevalier I, Gauthier M et al. Prospective evaluation of the management of moderate to severe cellulitis with parenteral antibiotics at a paediatric day treatment centre. J Paediatr Child Health 2008; 44: 214-8.
29. Brugha RE, Abrahamson E. Ambulatory intravenous antibiotic therapy for children with preseptal cellulitis. Pediatr Emerg Care 2012; 28: 226-8.
30. Yule EJ, Fryer J, Ross J. Periorbital cellulitis: ambulatory care that is safe and cost effective. Emergency Med J 2013; 30: 878-9.
31. McCarthy CA, Powell KR, Jaskiewicz JA et al. Outpatient management of selected infants younger than two months of age evaluated for possible sepsis. Pediatr Infect Dis J 1990; 9: 385-9.
32. Habib G, Hoen B, Tornos P et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30: 2369-413.
33. Partridge DG, O'Brien E, Chapman AL. Outpatient parenteral antibiotic therapy for infective endocarditis: a review of 4 years' experience at a UK centre. Postgrad Med J 2012; 88: 377-81.
34. Lin TY, Nelson JD, McCracken GH Jr. Fever during treatment for bacterial meningitis. Pediatr Infect Dis 1984; 3: 319-22.
35. Waler JA, Rathore MH. Outpatient management of pediatric bacterial meningitis. Pediatr Infect Dis J 1995; 14: 89-92.
36. Marcy MS. Outpatient management of bacterial meningitis. Pediatr Infect Dis J 1989; 8: 258-60.
37. Mortlock NJ, Schleis T. Outpatient parenteral antimicrobial therapy technology. Infect Dis Clin North Am 1998; 12: 861-78.
38. Madigan T, Banerjee R. Characteristics and outcomes of outpatient parenteral antimicrobial therapy at an academic children's hospital. Pediatr Infect Dis J 2013; 32: 346-9.
39. O'Grady NP, Alexander M, Dellinger EP et al. Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Center for Disease Control and Prevention, US. Pediatrics 2002; 110: e51.
40. Paladino JA, Poretz D. Outpatient parenteral antimicrobial therapy today. Clin Infect Dis 2010; 51 Suppl 2: S198-208.
41. NICE. Guidance on the Use of Ultrasound Locating Devices for Placing Central Venous Catheters 2002. http://www.nice.org.uk/guidance/ta49/.
42. Nichols I, Doellman D. Pediatric peripherally inserted central catheter placement: application of ultrasound technology. J Infus Nurs 2007; 30: 351-6.
43. Racadio JM, Doellman DA, Johnson ND et al. Pediatric peripherally inserted central catheters: complication rates related to catheter tip location. Pediatrics 2001; 107: E28.
44. Infusion Nurses Society. Infusion nursing standards of practice. J Infus Nurs 2006; 29: Suppl 1: S1-92.
45. Royal College of Nursing. Standards for Infusion. 2010. http:// ivtherapyathome.heartofengland.nhs.uk/wp-content/uploads/2013/05/ RCN-Guidlines-for-IV-therapy.pdf.
46. UK Department of Health. Saving Lives: Reducing Infection, Delivering Clean and Safe Care. 2007. http://webarchive.nationalarchives.gov.uk/+/ www.dh.gov.uk/en/Publicationsandstatistics/Publications/Publications PolicyAndGuidance/DH_078134.
47. Rathore MH. The unique issues of outpatient parenteral antimicrobial therapy in children and adolescents. Clin Infect Dis 2010; 51 Suppl 2: S209-15.
48. Hussain S, Gomez MM, Wludyka P et al. Survival times and complications of catheters used for outpatient parenteral antibiotic therapy in children. Clin Pediatr (Phila) 2007; 46: 247-51.
49. Rowley S, Clare S. ANTT: a standard approach to aseptic technique. Nurs Times 2011; 107: 12-4.
50. Idsoe O, Guthe T, Willcox RR et al. Nature and extent of penicillin sidereactions, with particular reference to fatalities from anaphylactic shock. Bull World Health Organ 1968; 38: 159-88.
51. Joint Formulary Committee. British National Formulary for Children, 2014. http://www.bnf.org/bnf/org_450055.htm.
52. NHS National Patient Safety Agency. Patient Safety Alert 20: Promoting Safer Use of Injectable Medicines, 2007. http://www.nrls.npsa.nhs.uk/ resources/?entryid45=59812.
53. Gilchrist M, Franklin BD, Patel JP. An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service. J Antimicrob Chemother 2008; 62: 177-83.
54. UK Department of Health. National Service Framework for Children, Young People and Maternity Services: Core Standards 2004. https://www. gov.uk/government/publications/national-service-framework-childrenyoung- people-and-maternity-services.
55. Bradley JS, Ching DK, Phillips SE. Outpatient therapy of serious pediatric infections with ceftriaxone. Pediatr Infect Dis J 1988; 7: 160-4.
56. Goldenberg RI, Poretz DM, Eron LJ et al. Intravenous antibiotic therapy in ambulatory pediatric patients. Pediatr Infect Dis 1984; 3: 514-7.
57. Bradley JS, Behrendt CE, Arrieta AC et al. Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis. Pediatr Infect Dis J 2001; 20: 19-24.
58. Dagan R, Fliss DM, Einhorn M et al. Outpatient management of chronic suppurative otitis media without cholesteatoma in children. Pediatr Infect Dis J 1992; 11: 542-6.
59. Niv A, Nash M, Peiser J et al. Outpatient management of acute mastoiditis with periosteitis in children. Int J Pediatr Otorhinolaryngol 1998; 46: 9-13.
60. Maraqa NF, Gomez MM, Rathore MH. Outpatient parenteral antimicrobial therapy in osteoarticular infections in children. J Pediatr Orthop 2002; 22: 506-10.
61. Nelson JD. Options for outpatient management of serious infections. Pediatr Infect Dis J 1992; 11: 175-8.
62. Copley LA. Pediatric musculoskeletal infection: trends and antibiotic recommendations. J Am Acad Orthop Surg 2009; 17: 618-26.
63. Skryabina EA, Dunn TS. Disposable infusion pumps. Am J Health Syst Pharm 2006; 63: 1260-8.
64. Moon YS, Chung KC, Chin A et al. Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags. Am J Health Syst Pharm 1995; 52: 999-1001.
65. Plumridge RJ, Rieck AM, Annus TP et al. Stability of ceftriaxone sodium in polypropylene syringes at 220, 4, and 20 degrees C. Am J Health Syst Pharm 1996; 53: 2320-3.
66. Stendal TL, KlemW, Tonnesen HH et al. Drug stability and pyridine generation in ceftazidime injection stored in an elastomeric infusion device. Am J Health Syst Pharm 1998; 55: 683-5.
67. Hubert D, Le Roux E, Lavrut Tet al. Continuous versus intermittent infusions of ceftazidime for treating exacerbation of cystic fibrosis. Antimicrob Agents Chemother 2009; 53: 3650-6.
68. McQuade MS, Van Nostrand V, Schariter J et al. Stability and compatibility of reconstituted ertapenem with commonly used i.v. infusion and coinfusion solutions. Am J Health Syst Pharm 2004; 61: 38-45.
69. Tho T-P CM, Elis AG,Williams L et al. Stability of intravenous flucloxacillin solutions used for hospital-in-the-home. J PharmPract Res 2010; 40: 101-5.
70. Leder K, Turnidge JD, Korman TM. The clinical efficacy of continuousinfusion flucloxacillin in serious staphylococcal sepsis. J Antimicrob Chemother 1999; 43: 113-8.
71. Dulhunty JM, Roberts JA, Davis JS et al. Continuous infusion of β-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial. Clin Infect Dis 2013; 56: 236-44.
72. Stiles ML, Allen LV Jr. Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium, and tobramycin sulfate in polyvinyl chloride drug reservoirs. Am J Health Syst Pharm 1997; 54: 1068-70.
73. Allen LV Jr, Stiles ML, Prince SJ et al. Stability of 14 drugs in the latex reservoir of an elastomeric infusion device. Am J Health Syst Pharm 1996; 53: 2740-3.
74. Patel AD, Anand D, Lucas C et al. Continuous infusion of vancomycin in neonates. Arch Dis Child 2013; 98: 478-9.
75. Tsiouris MP, Ulmer MM, Yurcho JFB et al. Stability and compatibility of reconstituted caspofungin in select elastomeric infusion devices. Int J Pharm Compd 2010; 14: 436-9.
76. Zhang Y, Trissel LA, Martinez JF et al. Stability of acyclovir sodium 1, 7, and 10 mg/mL in 5% dextrose injection and 0.9% sodium chloride injection. Am J Health Syst Pharm 1998; 55: 574-7.